THCP (Tetrahydrocannabiphorol)
A rare phytocannabinoid with potent in vitro CB1 binding but no human studies.
THCP is real—peer-reviewed and isolated from cannabis. Its CB1 receptor binding is genuinely ~33× tighter than THC in test tubes. But that lab number doesn't mean it gets you 33× higher in humans. Almost all THCP products sold today are semi-synthetic hemp-derived conversions, not plant extractions. There are zero controlled human studies. Marketing claims outrun the evidence by miles.
What THCP is
THCP — tetrahydrocannabiphorol — is a phytocannabinoid structurally related to Δ9-THC, not a terpene. The key difference is its seven-carbon (n-heptyl) alkyl side chain, compared to THC's five-carbon (n-pentyl) chain. Strong evidence[1]
It was first isolated and characterized by Citti and colleagues in 2019 from the Italian medicinal cannabis variety FM2, published in Scientific Reports. Strong evidence[1]
That side-chain length matters pharmacologically. Decades of structure–activity research on cannabinoids show that CB1 receptor binding affinity increases as the alkyl chain lengthens, peaking around 7–8 carbons. Strong evidence[2] THCP sits near that optimum. In isolated-receptor assays, its CB1 binding affinity (Ki ≈ 1.2 nM) is approximately 33× higher than Δ9-THC's in the same test. Strong evidence[1]
A matching cannabidiol analog, CBDP, was identified in the same 2019 report. Strong evidence[1]
Where THCP is found in cannabis
In the original 2019 discovery, THCP was detected in the FM2 chemovar at roughly 0.0029% by dry weight—about one thousandth the concentration of Δ9-THC in the same sample. Strong evidence[1] Subsequent analytical surveys have detected it in other chemovars at similarly trace levels. Strong evidence[3]
This has a crucial practical implication: almost no plant sold on the market naturally contains psychoactively relevant amounts of THCP. Products marketed as 'THCP gummies,' 'THCP vapes,' or 'THCP flower' are almost entirely made by semi-synthetic conversion from hemp-derived CBD, not extracted from high-THCP plants. Weak / limited[4]
The purity, isomeric composition (e.g., how much S,S vs. R,R enantiomer), and byproduct profile of these semi-synthetic products are not well characterized in peer-reviewed literature. This matters for safety assessment.
Aroma and sensory profile
THCP, like THC, is essentially odorless and tasteless in the concentrations present in cannabis. Cannabinoids do not produce the aroma of cannabis. That comes from terpenes—volatile compounds like myrcene and caryophyllene—and to a lesser extent from volatile sulfur compounds. Strong evidence[1]
If a product description tells you a flower 'smells like THCP,' you are reading a description of the terpene profile, not the cannabinoid content.
Effects research: in vitro, animal, and human data
In vitro (receptor binding in isolated cells): THCP binds the human CB1 receptor with approximately 33× the affinity of Δ9-THC, and CB2 with roughly 5–10× the affinity. Strong evidence[1] This is a solid, well-replicated in vitro result.
In animal models (mice): Citti et al. administered THCP to mice and ran the standard 'tetrad' assay—hypomotility, analgesia, catalepsy, and hypothermia—used to screen cannabinoids for THC-like effects. THCP produced THC-like responses at lower doses than THC in some measures, consistent with higher potency, though not by a clean 33× factor across all measures. Weak / limited[1] Notably, this is the only published animal-model study of isolated THCP.
In humans: There are no published controlled pharmacokinetic or pharmacodynamic studies of isolated THCP in people. No data Claims that THCP is '10×' or '33× stronger than THC' based on user experience are extrapolations from a receptor-binding number, not measurements of subjective intoxication, onset, or duration.
Receptor affinity is one input into a drug's real-world potency. Absorption, distribution, metabolism, whether the compound is a full vs. partial agonist, onset of tolerance, and individual variation all matter too. A 33-fold difference in CB1 binding does not reliably predict a 33-fold difference in human high. Weak / limited
Safety: No clinical safety data exist for isolated THCP in humans. Adverse-event reports tied to consumer THCP products are difficult to interpret because almost all commercial THCP is semi-synthetic, likely containing isomers and byproducts from the synthesis route. Weak / limited[4]
Strains and products marketed as 'high in THCP'
There are no established cannabis strains or cultivars marketed as 'high in THCP' in the way that growers might advertise 'high myrcene' or 'high limonene' strains, because THCP naturally occurs at trace levels across the chemovars studied. Strong evidence[1][3]
Marketing copy labeling specific cultivars as 'THCP strains' is not backed by routine certificates of analysis, which generally do not even test for THCP. Most commercial cannabinoid labs focus on Δ9-THC, CBD, and a handful of common minors; THCP quantitation requires specialized chromatography and is rarely offered. Disputed
If you encounter a product claiming a specific THCP percentage in flower (e.g., '2% THCP'), that claim is extraordinary and requires a third-party certificate of analysis from an accredited lab. Even then, verify the analytical method—HPLC, GC-MS, or other—and check that the lab has validated THCP quantitation against a reference standard.
Related cannabinoids
THCP is a phytocannabinoid, so the meaningful structural and pharmacological comparisons are to other cannabinoids, not to terpenes:
- Δ9-THC — the five-carbon parent compound; the benchmark THCP is most often compared to in receptor and animal studies.
- CBDP (cannabidiphorol) — the CBD analog with the same seven-carbon chain, co-discovered with THCP in 2019. Strong evidence[1]
- THCV (tetrahydrocannabivarin) — a three-carbon analog with different receptor pharmacology and purported effects.
- Δ8-THC and HHC — other semi-synthetic or minor cannabinoids commonly sold alongside THCP in unregulated markets.
If you are looking for information about terpene relationships and aroma, see myrcene, caryophyllene, and mango aroma in cannabis.
Bottom line
THCP is a real phytocannabinoid with interesting receptor pharmacology and zero human clinical data. The 33× CB1 binding affinity is a solid in vitro result; the marketing leap to 'gets you 33× higher' is unsupported and scientifically misleading. Weak / limited
Almost all THCP products on the market today are semi-synthetically derived from hemp-derived CBD, not plant extracts. Their purity and safety profile are poorly characterized. Until controlled human studies and better manufacturing standards exist, treat consumer THCP products as experimental compounds and dose conservatively, if at all. Weak / limited
Sources
- Peer-reviewed Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, Laganà A, Capriotti AL, Forni F, Vandelli MA, Gigli G, Cannazza G. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-tetrahydrocannabiphorol. Scientific Reports. 2019;9:20335.
- Peer-reviewed Bow EW, Rimoldi JM. The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation. Perspectives in Medicinal Chemistry. 2016;8:17–39.
- Peer-reviewed Linciano P, Citti C, Luongo L, Belardo C, Maione S, Vandelli MA, Forni F, Gigli G, Laganà A, Montone CM, Cannazza G. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabiphorol Quantification in Samples of Commercial Hemp. Journal of Natural Products. 2020;83(1):88-98.
- Government U.S. Food and Drug Administration. 5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC. FDA Consumer Updates. 2022.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Caryophyllene — A peppery sesquiterpene that activates CB2 receptors and appears in high concentrations in...
- Mango Aroma in Cannabis: Myrcene + Ocimene — How two monoterpenes blend to create the tropical-fruit smell some cannabis cultivars prod...
- The Myrcene 0.5% Threshold — A viral cannabis rule with no peer-reviewed evidence behind it.
- THC-O-acetate (THC-O) — A synthetic cannabinoid with limited human evidence and a documented vaping hazard.
- Volatile Sulfur Compounds in Cannabis — Tiny sulfur molecules responsible for skunk aroma, detected by the nose at parts-per-trill...